Skip to content

13F-HR filed by Sarissa Capital Management LP

Sarissa Capital Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:35:23 UTC, with 10 holding rows worth $153,172,008.

Accession
0001420506-26-002892
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 10 entries on the cover page, a total value of $153,172,008 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,172,008 with VALUE read as dollars as filed, 13F file number 028-15935. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INNOVIVA INC45781M101COM1,890,604$40,099,711dollars as filed
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK9,188,635$36,478,881dollars as filed
AMARIN CORP PLC023111404SPONSORED ADR1,287,090$16,732,170dollars as filed
LANTHEUS HLDGS INC516544103COM166,919$16,613,448dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM116,533$16,529,041dollars as filed
CYTOKINETICS INC23282W605COM NEW228,623$15,068,542dollars as filed
BIOHAVEN LTDG1110E107COM582,312$7,773,865dollars as filed
REGENERON PHARMACEUTICALS COM75886F107Stock4,190$3,177,151dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK25,399$484,613dollars as filed
BIOGEN INC COM09062X103Stock950$214,586dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002892this filing2026-11-16